有型新闻

发布于2021年2月9日 14:40 Clive Cookson and Anna Gross Initial evidence that the Oxford/AstraZeneca vaccine offered only “minimal” protection against mild to moderate cases of the Covid-19 variant first identified in South Africa has focused global attention on

字号+ 作者:孙文 来源: 2021-03-16 我要评论

FT英语电台关注 What we know about the most troublesome Covid mutations 我们对最棘手的新冠病毒突变的了解 E484K, the genetic change in the variant first identified in South Africa, is affecting the efficacy of some vac

is affecting the efficacy of some vaccines 在南非首次发现的变异基因E484K正在影响一些疫苗的疗效, FT英语电台关注 What we know about the most troublesome Covid mutations 我们对最棘手的新冠病毒突变的了解 E484K, the genetic change in the variant first identified in South Africa, 发布于2021年2月9日 14:40 Clive Cookson and Anna Gross Initial evidence that the Oxford/AstraZeneca vaccine offered only “minimal” protection against mild to moderate cases of the Covid-19 variant first identified in South Africa has focused global attention on the threat posed by mutations. Variants have become increasingly prevalent as the Sars-Cov-2 virus has spread around the world infecting more than 100m people. Some of the mutations have made the virus more contagious and better able to escape the immune protection provided by vaccines and prior infection. ,。

转载请注明出处。

1.本站遵循行业规范,任何转载的稿件都会明确标注作者和来源;2.本站的原创文章,请转载时务必注明文章作者和来源,不尊重原创的行为我们将追究责任;3.作者投稿可能会经我们编辑修改或补充。

相关文章
网友点评

关注微信
手机网站
关于我们